Disc Medicine Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
IRON$81.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| | March 31, | December 31, | |
|---|---|---|---|
| | 2024 | 2023 | |
| Assets · | |||
| Current assets: · | |||
| Cash and cash equivalents | | $342,615 | $360,382 |
| Prepaid expenses and other current assets | | 9,333 | 5,280 |
| Total current assets | | 351,948 | 365,662 |
| Property and equipment, net | | 211 | 170 |
| Right-of-use assets, operating leases | | 1,788 | 1,930 |
| Other assets | | 235 | 234 |
| Total assets | | $354,182 | $367,996 |
| Liabilities and Stockholders’ Equity | | ||
| Current liabilities: | | ||
| Accounts payable | | $5,269 | $12,629 |
| Accrued expenses | | 8,816 | 8,145 |
| Operating lease liabilities, current | | 767 | 665 |
| Total current liabilities | | 14,852 | 21,439 |
| Operating lease liabilities, non-current | | 1,259 | 1,436 |
| Total liabilities | | 16,111 | 22,875 |
| Commitments and contingencies (Note 13) | | ||
| Stockholders’ equity: | | ||
| Common stock, $0.0001 par value; 100,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 24,695,885 and 24,360,233 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | | 2 | 2 |
| Additional paid-in capital | | 553,663 | 533,764 |
| Accumulated deficit | | (215,594) | (188,645) |
| Total stockholders’ equity | | 338,071 | 345,121 |
| Total liabilities and stockholders’ equity | | $354,182 | $367,996 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.